AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Back to search results

IDR peptide therapy for allergic asthma

Detailed Technology Description: Peptides for the treatment of allergic conditions, such as allergic asthma and other Th-2 dysregulated inflammatory conditions.

*Abstract: A composition for treating or preventing a Th2-dysregulated inflammatory condition wherein the composition comprises a therapeutically effective amount of one or more IDR peptides. Use of IDR peptides or a composition comprising IDR peptides for treating or preventing a Th2-dysregulated inflammatory condition. The Th2-dysregulated inflammatory condition includes allergy or atopy, for example allergic asthma.

*Inquiry: Riya Ganguly,Ph.D.TechnologyManagerPh:+1(204)474.9466Email: riya.ganguly@umanitoba.ca

Country/Region: USA

For more information, please click Here